Hassan Osman Abuzaid

Medication error is an essential variable to determine patient safety. So it is crucial to realize the bottle necks of care giving. Studies proved that the role of clinical pharmacist can attribute to positive outcomes in patient care. The main objective is to assess the impact of the interventions provided by clinical pharmacist in the medical wards. Secondary objectives comprise of evaluating the impact of intervention in the patients with renal failure, assessing the acceptance by physician and estimating the effect of intervention in cost saving. The set of interventions collected are regrouped into various categories like indications, safety, dosing and miscellaneous. Under each category, sub-categories are listed and their respective percentages are explained using pictorial representation. Also, the acceptance rate of the interventions by the physician is calculated. The cost saving accrued because of the interventions is estimated to look into to know how the role of clinical pharmacist can help the patients economically. The interventions are regrouped into: indication – 36.3 %; safety – 40.8 %; dosing – 16.03 % and miscellaneous – 6.8 %. Majority of the interventions are given for safety and the acceptance rate of the interventions by the physicians is high – 87.2 %. It is also found that 40 % of these interventions accrued to cost saving to the patients. There is a possibility of multiple benefits, by allotting a clinical pharmacist for every medical team in the ward. This strategy helps the patients to gain better health care and cost saving.